PA
DMTK

Perceptive Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Perceptive Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-487,121
Closed -$6.45M – 145
2020
Q2 		$6.45M Buy
487,121
+201,265
+70% +$2.62M 0.1% 90
2020
Q1 		$3.21M Buy
+285,856
New +$3.51M 0.08% 84

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Perceptive Advisors's DMTK Position: Q3 2020 in Review

Perceptive Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2020, closing a stake of 487,121 shares — an estimated $6.45M sold.

Perceptive Advisors first reported a position in DMTK in Q1 2020 and held it in 2 quarters. The position peaked at $6.45M in Q2 2020. 48 funds tracked by Wall St. Rank hold DMTK as of Q3 2020.

  • Perceptive Advisors reported no remaining DermTech, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Perceptive Advisors sold 487,121 DermTech, Inc. Common Stock shares in Q3 2020, an estimated $6.45M.
  • Perceptive Advisors first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Perceptive Advisors's DermTech, Inc. Common Stock position peaked at $6.45M in Q2 2020.
  • 48 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2020.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.